HIGHLIGHTS
- who: Pingping Yang and Qinghua Wu from the University Medical Center Hamburg-Eppendorf, Germany have published the article: Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials, in the Journal: (JOURNAL) of 13/Dec/2021
- what: The subgroup analysis in this trial showed that sacubitril/valsartan had a beneficial effect on patients with an LVEF between 45 and 57% (RR: 0.78, 95% CI: 0.64-0.95).
- how: The results showed that patients receiving sacubitril/valsartan had a higher risk of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.